基于BATMAN-TCM在线分析平台的浙贝母-瓜蒌配伍治疗慢性阻塞性肺病的网络药理学研究

doi:10.3976/j.issn.1002-4026.2021.01.002

山东科学 ›› 2021, Vol. 34 ›› Issue (1): 10-20.doi: 10.3976/j.issn.1002-4026.2021.01.002

基于BATMAN-TCM在线分析平台的浙贝母-瓜蒌配伍治疗慢性阻塞性肺病的网络药理学研究

曹铭晨¹，徐龙¹，辛兆洋¹，方孟香²，邢晓敏¹，陈萧¹，汪川¹，魏欣欣¹，任炜^1*

1.青岛大学附属医院，山东青岛 266000；2.西海岸新区第二中医院，山东青岛 266400

收稿日期:2020-07-10 出版日期:2021-02-15 发布日期:2021-01-29
通信作者: 任炜（1977—），男，本科，主管药师，研究方向为临床药学。E-mail: rw0532@126.com E-mail:383642665@qq.com
作者简介:曹铭晨（1993—），男，硕士，药师，研究方向为临床药学和中药学。E-mail: 383642665@qq.com
基金资助:
青岛大学附属医院中药制剂培育专项基金（31-188-0）

Network pharmacology study of Fritillariae Thunbergii Bulbus - Trichosanthis Fructus compatibility for treating chronic obstructive pulmonary disease based on the BATMAN-TCM online analysis platform

CAO Ming-chen¹, XU Long ¹, XIN Zhao-yang¹, FANG Meng-xiang², XING Xiao-min¹,CHEN Xiao¹,WANG Chuan¹, WEI Xin-xin¹, REN Wei ^1*

1.The Affiliated Hospital of Qingdao University, Qingdao 266000, China; 2. West Coast New Area Second Hospital of Traditional Chinese Medicine, Qingdao 266500, China

Received:2020-07-10 Online:2021-02-15 Published:2021-01-29

摘要/Abstract

摘要： 基于中药分子机理的生物信息学分析工具（bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine，BATMAN-TCM）挖掘浙贝母-瓜蒌治疗慢性阻塞性肺病的分子作用机制。应用BATMAN-TCM预测浙贝母-瓜蒌的潜在靶点，GeneCards数据库检索慢性阻塞性肺病的靶点；应用Cytoscape 3.7.1软件构建化合物-疾病-靶点相互作用网络、蛋白质-蛋白质相互作用( protein-protein interaction，PPI) 网络，进行基因本体( gene ontology，GO) 功能富集分析和京都基因与基因组百科全书( Kyoto encyclopedia of genes and genomes,KEGG) 的生物通路富集分析。结果筛选得到浙贝母-瓜蒌中21种活性成分，基于STRING构建的浙贝母-瓜蒌靶点PPI网络包含131个节点和236条相互作用关系，关键节点包括ANXA1、EDN1、HDAC1、RXRA、ADRA2A、OXT、RXRB等。GO富集分析途径主要涉及离子门控通道活性、底物特异性通道活性、被动跨膜转运活性、细胞外配体门控离子通道活性、神经递质受体活性、配体门控离子通道活性等。KEGG通道分析主要涉及神经活动配体-受体相互作用、cAMP信号通路、钙离子信使通路、类胆碱能突触、逆行内源性大麻素信号传导、5-羟色胺能突触、多巴胺能突触等途径。研究结果提示浙贝母-瓜蒌关键的作用靶点包括ANXA1、HDAC1等，信号通路方面涉及类胆碱能、5-羟色胺、多巴胺等神经受体相关通路，体现了中药复方的整体性特点,为进一步研究浙贝母-瓜蒌的分子作用机制提供了新思路。

关键词: 浙贝母-瓜蒌; BATMAN-TCM , GO , KEGG, 网络药理学；慢性阻塞性肺病

Abstract: Based on the bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine (BATMAN-TCM), this study revealed the molecular mechanism of action of Fritillariae Thunbergii Bulbus-Trichosanthis Fructus (FTB-TF) for treating chronic obstructive pulmonary diseases (COPD). The BATMAN-TCM was adopted to predict the potential targets of FTB-TF, whereas the GeneCards database was used to search the targets of COPD. Cytoscape 3.7.1 software was used to construct a compound-disease-target interaction network and protein-protein interaction (PPI) network to conduct gene ontology (GO) enrichment analysis and pathway enrichment analysis based on the Kyoto encyclopedia of genes and genomes (KEGG). A total of 21 types of active ingredients were screened from FTB-TF, and the compound-disease-target network was constructed. The PPI network of FTB-TF targets was established based on STRING, and it included 131 nodes and 236 edges. Examples of the key nodes included ANXA1, EDN1, HDAC1, RXRA, ADRA2A, OXT, and RXRB. The GO enrichment analysis mainly involved ion-gated channel activity, substrate-specific channel activity, passive transmembrane transporter activity, extracellular ligand-gated ion channel activity, neurotransmitter receptor activity, and ligand-gated ion channel activity. The KEGG pathway analysis mostly involved neuroactive ligand-receptor interaction, cAMP signaling pathway, calcium signaling pathway, cholinergic synapse, retrograde endocannabinoid signaling, serotonergic synapse, and dopaminergic synapse. The results suggested that ANXA1 and HDAC1, for instance, were the key targets of FTB-TF. The signaling pathways primarily involved neuroreceptor pathways such as acetylcholine, serotonin, and dopamine. These findings reflected the overall characteristics of the Chinese medicine compound prescription, thereby providing new clues for further research on the molecular mechanism of action of FTB-TF.

Key words: Fritillariae Thunbergii Bulbus-Trichosanthis Fructus, BATMAN-TCM, GO, KEGG, network pharmacology;chronic obstructive pulmonary disease

中图分类号:

R285.5

曹铭晨, 徐龙, 辛兆洋, 方孟香, 邢晓敏, 陈萧, 汪川, 魏欣欣, 任炜. 基于BATMAN-TCM在线分析平台的浙贝母-瓜蒌配伍治疗慢性阻塞性肺病的网络药理学研究[J]. 山东科学, 2021, 34(1): 10-20.

CAO Ming-chen, XU Long, XIN Zhao-yang, FANG Ming-xiang, XING Xiao-min, CHEN Xiao, WANG Chuan, WEI Xin-xin, REN Wei. Network pharmacology study of Fritillariae Thunbergii Bulbus - Trichosanthis Fructus compatibility for treating chronic obstructive pulmonary disease based on the BATMAN-TCM online analysis platform[J]. Shandong Science, 2021, 34(1): 10-20.

参考文献 25

1.	谢文英, 包永生, 王俊月, 等. 中医药防治慢性阻塞性肺疾病炎症反应相关信号通路的研究进展[J]. 中国实验方剂学杂志, 2019, 25(23): 1-8. doi: 10.13422/j.cnki.syfjx.20191307
2.	黎红芳, 王玲.稳定期慢性阻塞性肺病中医治疗研究进展[J].新疆中医药,2019,37(6):112-114.
3.	赵文翰, 禤美玲, 许坚, 等. 3096例慢性阻塞性肺疾病住院患者的临床及中医证候特征分析[J]. 广州中医药大学学报, 2020, 37(5): 806-812. doi: 10.13359/j.cnki.gzxbtcm.2020.05.003
4.	曹铭晨, 于振英, 辛兆洋, 等. 基于网络药理学的五苓散多成分-多靶点-多通路作用机制研究[J].山东科学,2020,33(1):51-60. doi: 10.3976 /j.issn.1002-4026.2020.01.008
5.	LIU Z Y, GUO F F, WANG Y, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine[J]. Scientific Reports, 2016, 6: 21146. doi: 10.1038/srep21146
6.	RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of Cheminformatics, 2014, 6: 13. DOI:10.1186/1758-2946-6-13.
7.	SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Research, 2003, 13(11): 2498-2504. doi: 10.1101/gr.1239303
8.	HUANG D W, SHERMAN B T, LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nature Protocols, 2009, 4(1): 44-57. doi: 10.1038/nprot.2008.211
9.	KANEHISA LAB. KEGG:Kyoto Encyclopedia of Genes and Genomes [EB/OL].[2020-05-23]. https://www.kegg.jp/kegg.
10	SZKLARCZYK D, GABLE A L, LYON D, et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J]. Nucleic Acids Research, 2019, 47(D1): D607-D613. DOI:10.1093/nar/gky1131.
11	The R Foundation. The R project for statistical computing [EB/OL].[2020-05-13]. https://www.r-project.org.
12	李丹, 郑裕鹏, 邱玉杏, 等. HNL、ANXA1 mRNA表达水平与COPD合并肺部感染病原菌分布及药物敏感性的关系[J].热带医学杂志,2019,19(10):1233-1236.
13	窦丽阳, 徐治波, 冯玉麟. 组蛋白乙酰转移酶/组蛋白去乙酰基酶在慢性阻塞性肺疾病发病机制和治疗中的研究进展[J]. 国际呼吸杂志, 2007,27(19):1463-1466.
14	陈黛诗, 柯朝阳, 陈雷. 组蛋白去乙酰化酶在呼吸道相关疾病中的作用及展望[J]. 解放军医学杂志, 2017, 42(11): 962-967. doi: 10.11855/j.issn.0577-7402.2017.11.05
15	曹路, 高宝安, 官莉,等. 慢阻肺患者血清中组蛋白去乙酰化酶2 IL-1βIL-6及IL-17A的水平及临床意义[J]. 河北医学, 2019,25(10):1585-1588. doi: 10.3969 /j.issn.1006-6233.2019.10.001
16	黄文锋, 陈斯宁, 吴嘉冬,等. 中医药治疗慢性阻塞性肺疾病中调节HDAC-2研究进展[J]. 辽宁中医杂志, 2019, 46(9):2003-2005. doi: 10.13192/j.issn.1000-1719.2019.09.063
17	SHAO W,ZHANG S Z,TANG M,et al.Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin[J]. Nature, 2013, 494(7435): 90-94. doi: 10.1038/nature11748
18	BIRRELL M A, CRISPINO N, HELE D J, et al. Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD[J]. British Journal of Pharmacology, 2002, 136(4): 620-628. doi: 10.1038/sj.bjp.0704758
19	李刚. 多巴胺治疗慢性阻塞性肺疾病合并心力衰竭的效果观察[J]. 吉林医学, 2014, 35(32): 7131.
20	贺蓓, 沈宁. 抗胆碱能药物治疗慢性阻塞性肺疾病作用的新进展[J]. 中华结核和呼吸杂志, 2011, 34(4): 254-255. doi: 10.3760/cma.j.issn.1001-0939.2011.04.008
21	李雪芹, 李运景, 赵伟国, 等. 5-羟色胺转运体基因多态性与慢性阻塞性肺疾病相关性研究[J]. 中国药理学通报, 2017, 33(5): 681-684. doi: 10.3969/j.issn.1001-1978.2017.05.018
22	李雪芹, 李运景, 缪炯燏, 等. 慢性阻塞性肺疾病血小板5-羟色胺变化及意义[J]. 中国现代医学杂志, 2011, 21(5): 612-616.
23	陈汉桂. 心痛定、多巴胺治疗慢性阻塞性肺疾病心肺功能不全的疗效[J]. 中国医药指南, 2018,16(1):125-126.
24	何文芬, 郑玉国. 心痛定多巴胺治疗COPD心肺功能不全疗效观察[J]. 黑龙江医学, 2002, 26(3): 202.
25	赖瑜华, 沈俊良. 硝苯地平联合多巴胺治疗慢性阻塞性肺疾病心肺功能不全的疗效观察[J].临床合理用药杂志,2019,12(31):45-46. doi: 10.15887/j.cnki.13-1389/r.2019.31.021

[1]	曹铭晨, 于振英, 辛兆洋, 徐龙, 杨智威, 任炜, 邢晓敏, 荆凡波. 基于网络药理学的五苓散多成分-多靶点-多通路作用机制研究[J]. 山东科学, 2020, 33(1): 51-60.
[2]	闫建文，魏玉光. 基于成本与时效的铁路空车调配优化模型研究[J]. 山东科学, 2017, 30(4): 73-79.
[3]	郝娜，宋瑞，刘星材. 基于成本最小的公交人员排班优化模型[J]. J4, 2014, 27(2): 76-82.

基于BATMAN-TCM在线分析平台的浙贝母-瓜蒌配伍治疗慢性阻塞性肺病的网络药理学研究

Network pharmacology study of Fritillariae Thunbergii Bulbus - Trichosanthis Fructus compatibility for treating chronic obstructive pulmonary disease based on the BATMAN-TCM online analysis platform

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 3

Metrics

本文评价

推荐阅读 0